Skip to main content

Incannex welcomes world-leading psychedelics experts to advisory board

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incannex Healthcare Ltd (ASX:IHL, NASDAQ: IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and science experts to its Clarion Clinics Group Advisory Board. The Clarion Clinics Groups Pty Ltd is a collaborative venture between Incannex and three leading Australian psychedelics experts - Dr Paul Liknaitzky, Professor Suresh Sundram and Sean O’Carroll.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Jonathan@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  263.30
+3.60 (1.39%)
AAPL  269.86
-0.85 (-0.31%)
AMD  334.62
+11.41 (3.53%)
BAC  52.62
-0.04 (-0.08%)
GOOG  346.76
-0.74 (-0.21%)
META  670.50
-0.84 (-0.12%)
MSFT  422.64
-6.61 (-1.54%)
NVDA  208.40
-4.77 (-2.24%)
ORCL  162.07
-3.89 (-2.34%)
TSLA  371.85
-4.17 (-1.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.